Back to all news
New Report Highlights Clinical AI Performance, Sustainability, and Adoption Challenges
A multi-institutional review details key challenges, progress, and sustainability concerns in deploying clinical AI in real-world healthcare settings.
Key Details
- 1ARISE network (Stanford, Harvard, Virginia, Minnesota) reviewed high-impact 2025 clinical AI studies.
- 2Real-world impact lags behind model capabilities, with few studies demonstrating measurable outcomes.
- 3Frontier LLMs excel in reasoning but struggle with uncertainty or context change.
- 4Clinicians value workflow automation, but key target use cases are understudied.
- 5FDA clearance for AI is increasing, but narrow, domain-specific tools are most likely to gain adoption.
- 6Sustainability concerns rise; AI models and data centers contribute significant carbon emissions.
Why It Matters
This review provides evidence-based guidance for translating AI advances from research to practice, underscoring the importance of rigorous standards, transparency, and sustainability. Imaging AI professionals should note the trend toward regulatory approvals and practical clinical impact, as well as institutional responsibility for environmental considerations.
Source
HealthExec
Related News
•HealthExec
Mayo Clinic Sued Over Alleged AI Improprieties and Whistleblower Retaliation
A former Mayo Clinic research director sues the institution, alleging retaliation after raising concerns about improper AI use affecting patient safety and data integrity.
•Radiology Business
Framework Assesses Real-World Financial Impact of Radiology AI Adoption
A new analysis presents a financial calculator for objectively assessing the return on investment (ROI) of implementing radiology AI solutions.
•Radiology Business
AI Technique Unveils Previously Hidden MS Gray Matter Lesions on MRI
Researchers developed an AI-enhanced method to detect previously invisible gray matter lesions in multiple sclerosis using MRI.